You searched for lung cancer | Page 49 of 166

Foundation Medicine and Bristol Myers Squibb Expand Collab on CDx Development

Posted by Andy Lundin | Apr 11, 2023 | Cancer |

Foundation Medicine and Bristol Myers Squibb are developing the FoundationOne CDx as a companion diagnostic for repotrectinib.

A simple blood draw can help determine if peptide receptor radionuclide therapy is effective in a patient with neuroendocrine cancer.

Posted by Andy Lundin | Apr 4, 2023 | Cancer |

Stilla Technologies and Atila BioSystems agreed to market digital PCR kits and assays produced by Atila for use on Stilla’s naica system.

Posted by Andy Lundin | Mar 27, 2023 | Cancer |

SEngine has been certified through the NY State Department of Health’s CLEP program to perform the PARIS Test on samples from the state.

Posted by Andy Lundin | Mar 22, 2023 | Cancer |

A co-location model for cancer diagnostic services reported a reduction in the time it took to diagnose cancer at a community health center.